Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone-sparing Based on NEPA With Olanzapine for CINV
NCT06331520Phase 3Completed
- Sponsor
- Fudan University
- Start
- May 2024
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in chemotherapy-induced nausea and vomiting (CINV), sponsored by Fudan University. Started May 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT06331520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06331520.